Cristal Therapeutics

OverviewSuggest Edit

Cristal Therapeutics is a clinical-stage pharmaceutical company developing targeted nanomedicines with therapeutic profiles for the treatment of cancer and other diseases. Its product candidates are based on the proprietary polymeric nanoparticle construct called CriPec. Additionally, the company provides the CliCr chemistry platform. Cristal Therapeutics serves the nanomedicines, therapeutics, biomaterials, and diagnostics sectors.
TypePrivate
Founded2011
HQMaastricht, NL
Websitecristaltherapeutics.com

Latest Updates

Employees (est.) (Nov 2021)11
Cybersecurity ratingBMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Cristal Therapeutics

Werner Cautreels

Werner Cautreels

Chairman
Axel Mescheder

Axel Mescheder

CEO and CMO
Cristianne Rijcken

Cristianne Rijcken

CSO and Founder
André Verwei

André Verwei

Chief Finance Officer
Show more

Cristal Therapeutics Office Locations

Cristal Therapeutics has an office in Maastricht
Maastricht, NL (HQ)
Oxfordlaan 55
Show all (1)

Cristal Therapeutics Financials and Metrics

Summary Metrics

Founding Date

2011

Cristal Therapeutics total Funding

$26.8 m

Cristal Therapeutics latest funding size

$2.98 m

Time since last funding

4 years ago

Cristal Therapeutics investors

Cristal Therapeutics's latest funding round in November 2017 was reported to be $3 m. In total, Cristal Therapeutics has raised $26.8 m
Show all financial metrics

Cristal Therapeutics Cybersecurity Score

Cybersecurity ratingPremium dataset

B

83/100

SecurityScorecard logo

Cristal Therapeutics Online and Social Media Presence

Embed Graph

Cristal Therapeutics News and Updates

Cristal Therapeutics and Intravacc Announce Strategic Collaboration to Advance Novel Vaccine Platforms

BILTHOVEN, Netherlands and MAASTRICHT, Netherlands, Jan. 6, 2021 /PRNewswire/ -- Intravacc, a world leader in translational research and development of vaccines, and Cristal Therapeutics, a technology leader in enabling safer and more effective therapeutics, today announced a strategic...

Cristal Therapeutics announces a publication in 'Chemical Science' on CliCr® technology platform, comprising a new class of superior copper free click reagents for conjugation of small molecules, biologics, nanoparticles and other moieties

MAASTRICHT, The Netherlands, Sept. 29, 2020 /PRNewswire/ -- Cristal Therapeutics, a Dutch phase 2 clinical-stage pharmaceutical company developing targeted nanomedicines for the treatment of cancer and other diseases with high unmet patient need, announces publication in Chemical Science,...

Cristal Therapeutics Blogs

Cristal Therapeutics announces a publication in ‘Chemical Science’ on CliCr® technology platform, comprising a new class of superior copper free click reagents for conjugation of small molecules, biologics, nanoparticles and other moieties

Flagship chemistry journal describes the development of TMTHSI (CliCr®) as a superior click reagent Cristal applies the CliCr® platform to the rational design of CriPec® nanomedicines, also enabling modular CriVac® vaccine product development CliCr® can be partnered or licensed as a stand-alone tech…

Cristal Therapeutics Frequently Asked Questions

  • When was Cristal Therapeutics founded?

    Cristal Therapeutics was founded in 2011.

  • Who are Cristal Therapeutics key executives?

    Cristal Therapeutics's key executives are Werner Cautreels, Axel Mescheder and Cristianne Rijcken.

  • How many employees does Cristal Therapeutics have?

    Cristal Therapeutics has 11 employees.

  • Who are Cristal Therapeutics competitors?

    Competitors of Cristal Therapeutics include Plus Therapeutics, NexImmune and Cureport.

  • Where is Cristal Therapeutics headquarters?

    Cristal Therapeutics headquarters is located at Oxfordlaan 55, Maastricht.

  • Where are Cristal Therapeutics offices?

    Cristal Therapeutics has an office in Maastricht.

  • How many offices does Cristal Therapeutics have?

    Cristal Therapeutics has 1 office.